-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Albireo Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2021.
- Albireo Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$37.8M, a 166% decline year-over-year.
- Albireo Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$131M, a 174% decline year-over-year.
- Albireo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$34M, a 68.4% increase from 2020.
- Albireo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$108M, a 71.6% decline from 2019.
- Albireo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$62.7M, a 36% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)